ESR1 and invasive breast carcinoma: Moreover, invasive breast cancer includes at least four major molecular subtypes, which differ by their expression of estrogen receptor alpha (ER), progesterone receptor (PR), receptor tyrosine-protein kinase erbB-2 (Her2), and the proliferative status of the tumor [3, 4].